Christopher Dupont

Christopher Dupont is a seasoned professional in translational sciences and clinical biomarker development, currently serving as Associate Director of Translational Sciences at US WorldMeds since August 2025. Prior to this role, Christopher held the position of Associate Director and Clinical Translational Lead at Adaptimmune, focusing on the TECELRA program. Previous experience includes roles as Principal Scientist and Senior Scientist at Oncorus, where Christopher led clinical biomarker initiatives, and as a Scientist II at Agenus, designing biomarker plans for multiple clinical trials. Academic background includes a PhD in Cell/Cellular and Molecular Biology from the University of Pennsylvania, postdoctoral research at MIT, and foundational training as a Graduate Student at the University of Pennsylvania. Christopher's early research contributions include work at the Miltello Laboratory and an undergraduate degree from SUNY Geneseo.